Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma
Abroad (travel likely)RecruitingPHASE1
Conditions
Locally Recurrent Head and Neck Squamous Cell Carcinoma · Metastatic Head and Neck Squamous Cell Carcinoma · Refractory Head and Neck Squamous Cell Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
Contact: Principal Investigator (Shyam S. Rao, MD, PhD)University of Colorado Denver | Anschutz Medical Campus, Aurora, Colorado, United States
Contact: Principal Investigator (Alice N Weaver, MD, PhD)
Study leads
Shyam S.D. Rao, MD, PhD
Principal Investigator
University of California, Davis